Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 59.12% | 11.93% | 10.27% | -4.74% | -35.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.30% | 12.90% | 9.77% | -5.04% | -34.18% |
| Operating Income | -56.30% | -12.90% | -9.77% | 5.04% | 34.18% |
| Income Before Tax | -58.92% | -13.60% | -6.60% | 4.77% | 34.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.92% | -13.60% | -6.60% | 4.77% | 34.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.92% | -13.60% | -6.60% | 4.77% | 34.53% |
| EBIT | -56.30% | -12.90% | -9.77% | 5.04% | 34.18% |
| EBITDA | -56.77% | -12.98% | -9.88% | 4.96% | 34.34% |
| EPS Basic | -52.00% | -12.12% | -6.25% | 5.41% | 34.21% |
| Normalized Basic EPS | -47.06% | -13.64% | -9.52% | 4.17% | 29.17% |
| EPS Diluted | -52.00% | -12.12% | -6.25% | 5.41% | 34.21% |
| Normalized Diluted EPS | -47.06% | -13.64% | -9.52% | 4.17% | 29.17% |
| Average Basic Shares Outstanding | 4.42% | 3.14% | 2.03% | 1.13% | 0.53% |
| Average Diluted Shares Outstanding | 4.42% | 3.14% | 2.03% | 1.13% | 0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |